Durvalumab and tremelimumab for hepatocellular carcinoma in patients listed for a liver transplant.

Sohal, D; Moreland, K; Quillin, R; Lemon, K; Rojan, A; Olowokure, OO; Shah, S

JOURNAL OF CLINICAL ONCOLOGY, 2023; 41 (): TPS638